Asia-Pacific surgical navigation system market is expected to witness fastest growth, mainly due to aging population, rising incidence of burns cases, increasing diabetic patients, and per capita income. Elderly people have a slow healing of wounds as they have reduced regenerative capabilities and weak immune system, which leads to different ailments, thereby boosting the market for surgical navigation systems in the region. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the number of people aged 65 years and above, constituted approximately 11.4% of population in 2013, and the count is estimated to reach approximately 20% of the population by 2050.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/surgical-navigation-system-market/report-sample

According to the Asian Diabetes Prevention Initiative (ADPI), around 60% of diabetics in the world live in the region. It is also expected that without intervention, both China and India together, will have almost half a billion of population suffering from diabetes, by 2030. Diabetes is one of the major causes for rising cases of cardiac problems, due to which, the surgical navigation system market in the region is likely to witness considerable growth in future.

Surgical navigation systems are used for several applications such as neuro navigation, orthopedic navigation, ENT navigation, dental navigation, and cardiac navigation system. Globally, neuro navigation systems occupied the largest share in the market in 2016 and is also expected to grow at a faster pace attaining CAGR of 7.7% by 2023. The neuro navigation system provides real-time intraoperative guidance during brain and/or spinal surgery, leading to its growing market demand.

Globally, the key providers in the surgical navigation system industry are collaborating to gain a larger market share. For instance, in June 2017, Elekta AB, a company providing radiation therapy, radiosurgery, related equipment and clinical management for the treatment of cancer and brain disorders and Brainlab AG, entered into an agreement, according to which, Brainlab AG was made the authorized distributor of Elekta’s stereotactic solutions for neurosurgery in select markets in the Europe namely; France, Belgium, Poland, Liechtenstein, Luxemburg, Portugal and Spain.

Some of the other key players operating in the surgical navigation system market include Koninklijke Philips N.V., Fiagon GmbH, Orthalign, Inc., Stryker Corporation, Scopis GmbH, Medtronic plc, Siemens AG, General Electric Company, B. Braun Melsungen AG and Zimmer Biomet Holdings, Inc.

Know more: https://www.psmarketresearch.com/market-analysis/surgical-navigation-system-market